Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death

Journal of Leukocyte Biology

Volumn 81, Issue 2, 2007, Pages 539-547

  Mehrotra, Shikhar ^a,b   Chhabra, Arvind ^a   Hegde, Upendra ^a   Chakraborty, Nitya G ^a   Mukherji, Bijay ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

AICD; CTL; JNK

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; MATRIX PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; INFLUENZA; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL;

ANTHRACENES; APOPTOSIS; BIOLOGICAL MARKERS; CELL DEATH; CELLS, CULTURED; COCULTURE TECHNIQUES; EPITOPES, T-LYMPHOCYTE; HUMANS; INFLUENZA A VIRUS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PROTEIN KINASE INHIBITORS; SENSITIVITY AND SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

EID: 33846697037     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0706479     Document Type: Article

References (36)

1. Lenardo, M. J. (2003) Molecular regulation of T lymphocyte homeostasis in the healthy and diseased immune system. Immunol. Res. 27, 387-398.
2. Zheng, L., Boehme, S. A., Critchfield, J. M., Zuniga-Pflucker, J. C., Freedman, M., Lenardo, M. J. (1994) Immunological tolerance by antigen-induced apoptosis of mature T lymphocytes. Adv. Exp. Med. Biol. 365, 81-89.
3. Mehrotra, S., Chhabra, A., Chattopadhyay, S., Dorsky, D. I., Chakraborty, N. G., Mukherji, B. (2004) Rescuing melanoma epitope-specific cytolytic T lymphocytes from activation-induced cell death, by SP600125, an inhibitor of JNK: implications in cancer immunotherapy. J. Immunol. 173, 6017-6024.
4. Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118.
5. Mehrotra, S., Stevens, R., Zengou, R., Chakraborty, N. G., Butterfield, L. H., Economou, J. S., Dorsky, D. I., Mukherji, B. (2003) Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro. Cancer Res. 63, 5607-5614.
6. Xu, X. N., Purbhoo, M. A., Chen, N., Mongkolsapaya, J., Cox, J. H., Meier, U. C., Tafuro, S., Dunbar, P. R., Sewell, A. K., Hourigan, C. S., Appay, V., Cerundolo, V., Burrows, S. R., McMichael, A. J., Screaton, G. R. (2001) A novel approach to antigen-specific deletion of CTL with minimal cellular activation using α3 domain mutants of MHC class I/peptide complex. Immunity 14, 591-602.
7. Metivier, D., Dallaporta, B., Zamzami, N., Larochette, N., Susin, S. A., Marzo, I., Kroemer, G. (1998) Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes. Immunol. Lett. 61, 157-163.
8. Mukherji, B., Guha, A., Chakraborty, N. G., Sivanandham, M., Nashed, A. L., Sporn, J. R., Ergin, M. T. (1989) Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J. Exp. Med. 169, 1961-1976.
9. Lenardo, M. J. (1991) Interleukin-2 programs mouse α β T lymphocytes for apoptosis. Nature 353, 858-861.
10. Waldmann, T. A., Dubois, S., Tagaya, Y. (2001) Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14, 105-110.
11. Sallusto, F., Geginat, J., Lanzavecchia, A. (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22, 745-763.
12. O'Connell, A. R., Lee, B. W., Stenson-Cox, C. (2006) Caspase-dependent activation of chymotrypsin-like proteases mediates nuclear events during Jurkat T cell apoptosis. Biochem. Biophys. Res. Commun. 345, 608-616.
13. Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., Ben-Neriah, Y. (1994) JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77, 727-736.
14. Rivas, F. V., O'Herrin, S., Gajewski, T. F. (2001) CD28 is not required for c-Jun N-terminal kinase activation in T cells. J. Immunol. 167, 3123-3128.
15. Nelson, B. H., Willerford, D. M. (1998) Biology of the interleukin-2 receptor. Adv. Immunol. 70, 1-81.
16. Michel, J., Pauly, S., Langstein, J., Krammer, P. H., Schwarz, H. (1999) CD137-induced apoptosis is independent of CD95. Immunology 98, 42-46.
17. Cooper, D., Bansal-Pakala, P., Croft, M. (2002) 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur. J. Immunol. 32, 521-529.
18. Cannons, J. L., Hoeflich, K. P., Woodgett, J. R., Watts, T. H. (1999) Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB. J. Immunol. 163, 2990-2998.
19. Grayson, J. M., Laniewski, N. G., Lanier, J. G., Ahmed, R. (2003) Mitochondrial potential and reactive oxygen intermediates in antigen-specific CD8+ T cells during viral infection. J. Immunol. 170, 4745-4751.
20. Badovinac, V. P., Porter, B. B., Harty, J. T. (2002) Programmed contraction of CD8(+) T cells after infection. Nat. Immunol. 3, 619-626.
21. Lenardo, M., Chan, K. M., Hornung, F., McFarland, H., Siegel, R., Wang, J., Zheng, L. (1999) Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221-253.
22. Moskophidis, D., Lechner, F., Pircher, H., Zinkernagel, R. M. (1993) Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362, 758-761.
23. Rathmell, J. C., Thompson, C. B. (2002) Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109 (Suppl,), S97-107.
24. Jaattela, M., Tschopp, J. (2003) Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4, 416-423.
25. Nussbaum, A. K., Whitton, J. L. (2004) The contraction phase of virus-specific CD8+ T cells is unaffected by a pan-caspase inhibitor. J. Immunol. 173, 6611-6618.
26. Dong, C., Davis, R. J., Flavell, R. A. (2002) MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55-72.
27. Sabapathy, K., Hu, Y., Kallunki, T., Schreiber, M., David, J. P., Jochum, W., Wagner, E. F., Karin, M. (1999) JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 9, 116-125.
28. Ham, J., Eilers, A., Whitfield, J., Neame, S. J., Shah, B. (2000) c-Jun and the transcriptional control of neuronal apoptosis. Biochem. Pharmacol. 60, 1015-1021.
29. Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., Ichijo, H. (2001) ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2, 222-228.
30. Kroemer, G., Martin, S. J. (2005) Caspase-independent cell death. Nat. Med. 11, 725-730.
31. Karin, M. (1998) Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. N. Y. Acad. Sci. 851, 139-146.
32. Whitton, J. L., Slifka, M. K., Liu, F., Nussbaum, A. K., Whitmire, J. K. (2004) The regulation and maturation of antiviral immune responses. Adv. Virus Res. 63, 181-238.
33. Pantaleo, G., Soudeyns, H., Demarest, J. F., Vaccarezza, M., Graziosi, C., Paolucci, S., Daucher, M., Cohen, O. J., Denis, F., Biddison, W. E., Sekaly, R. P., Fauci, A. S. (1997) Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc. Natl. Acad. Sci. USA 94, 9848-9853.
34. Subbarao, K., Murphy, B. R., Fauci, A. S. (2006) Development of effective vaccines against pandemic influenza. Immunity 24, 5-9.
35. Manning, A. M., Davis, R. J. (2003) Targeting JNK for therapeutic benefit: from junk to gold? Nat. Rev. Drug Discov. 2, 554-565.
36. Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S. S., Manning, A. M., Anderson, D. W. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98, 13681-13686.